Anton I. Rosenbaum

1.8k total citations
32 papers, 1.1k citations indexed

About

Anton I. Rosenbaum is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Anton I. Rosenbaum has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Oncology. Recurrent topics in Anton I. Rosenbaum's work include HER2/EGFR in Cancer Research (12 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Lysosomal Storage Disorders Research (5 papers). Anton I. Rosenbaum is often cited by papers focused on HER2/EGFR in Cancer Research (12 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Lysosomal Storage Disorders Research (5 papers). Anton I. Rosenbaum collaborates with scholars based in United States, United Kingdom and Singapore. Anton I. Rosenbaum's co-authors include Frederick R. Maxfield, Guangtao Zhang, J. David Warren, Yue Huang, Daniel E Jonas, Sucharit Bhakdi, Meina Liang, Si Mou, Olaf Wiest and Christopher J. Mariani and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and PLoS ONE.

In The Last Decade

Anton I. Rosenbaum

31 papers receiving 1.0k citations

Peers

Countries citing papers authored by Anton I. Rosenbaum

Since Specialization

Citations

This map shows the geographic impact of Anton I. Rosenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton I. Rosenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton I. Rosenbaum more than expected).

Fields of papers citing papers by Anton I. Rosenbaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anton I. Rosenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton I. Rosenbaum. The network helps show where Anton I. Rosenbaum may publish in the future.

Co-authorship network of co-authors of Anton I. Rosenbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Anton I. Rosenbaum. A scholar is included among the top collaborators of Anton I. Rosenbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anton I. Rosenbaum. Anton I. Rosenbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and qualification of an LC-MS/MS method for quantification of MUC5AC and MUC5B mucins in spontaneous sputum 2025 ·Bioanalysis ·Weiwen Sun, Si Mou, (unknown), (unknown), Ian C. Scott, Aoife Kelly, Monica L. Gavala, (unknown), (unknown), Neil E. Alexis, (unknown), (unknown), (unknown), Moucun Yuan, William Mylott, Kévin Contrepois, Anton I. Rosenbaum	1
2	In-vitro metabolite identification for MEDI7219, an oral GLP-1 analog, using LC-MS/MS with CID and EAD approaches 2025 ·Bioanalysis ·(unknown), (unknown), (unknown), (unknown), Anton I. Rosenbaum	1
3	Investigations of Enteric-Coated Tablet Propyl Gallate-Induced Nephrotoxicity in Beagles as well as Human and Dog Renal Proximal Tubule Epithelial Cells 2025 ·ACS Pharmacology & Translational Science ·Si Mou, B. Timothy Hummer, Jiaqi Yuan, Yue Huang, Meina Liang, Raffaella Faggioni, Lorin Roskos, Anton I. Rosenbaum	0
4	Detailed Structural Elucidation of Antibody-Drug Conjugate Biotransformation Species Using High Resolution Multiple Reaction Monitoring Mass Spectrometry with Orthogonal Dissociation Methods 2024 ·ACS Pharmacology & Translational Science ·(unknown), (unknown), Jiaqi Yuan, Yue Huang, Anton I. Rosenbaum	5
5	Extensive Biotransformation Profiling of AZD8205, an Anti-B7-H4 Antibody-Drug Conjugate, Elucidates Pathways Underlying Its Stability In Vivo 2024 ·Analytical Chemistry ·Yue Huang, (unknown), Jiaqi Yuan, (unknown), (unknown), Kathryn Ball, Balakumar Vijayakrishnan, Luke A. Masterson, Krista Kinneer, Nadia Luheshi, Meina Liang, Anton I. Rosenbaum	9
6	Digestion-Free Middle-Down Mass Spectrometry Method for Absolute Quantification of Conjugated Payload from Antibody-Drug Conjugates 2024 ·Analytical Chemistry ·Jiaqi Yuan, (unknown), Yue Huang, Anton I. Rosenbaum	7
7	Robust and High-Throughput Analytical Flow Proteomics Analysis of Cynomolgus Monkey and Human Matrices With Zeno SWATH Data-Independent Acquisition 2023 ·Molecular & Cellular Proteomics ·Weiwen Sun, (unknown), Yue Huang, (unknown), (unknown), Anton I. Rosenbaum, Kévin Contrepois	7
8	Systems Biology and Peptide Engineering to Overcome Absorption Barriers for Oral Peptide Delivery: Dosage Form Optimization Case Study Preceding Clinical Translation 2023 ·Pharmaceutics ·Puneet Tyagi, Chandresh Patel, (unknown), (unknown), Sergei Pechenov, Sarah Will, Jefferson D. Revell, Yue Huang, Anton I. Rosenbaum, Kemal Balic, (unknown), Joseph Grimsby, J. Anand Subramony	6
9	Multiplex Bioanalytical Methods for Comprehensive Characterization and Quantification of the Unique Complementarity-Determining-Region Deamidation of MEDI7247, an Anti-ASCT2 Pyrrolobenzodiazepine Antibody–Drug Conjugate 2023 ·Antibodies ·Yue Huang, Jiaqi Yuan, (unknown), Robert Kubiak, Kathryn Ball, Mingyan Cao, (unknown), (unknown), Dengfeng Liu, Lorin Roskos, Meina Liang, Anton I. Rosenbaum	7
10	Multiplex Hybrid Antigen-Capture LC-MRM Quantification in Sera and Nasal Lining Fluid of AZD7442, a SARS-CoV-2-Targeting Antibody Combination 2022 ·Analytical Chemistry ·(unknown), Yue Huang, Jérôme Bouquet, Jiaqi Yuan, Robert Kubiak, Eric Ma, (unknown), William Mylott, Omnia A. Ismaiel, (unknown), (unknown), Diego Fernando Marmolejo Cortes, James Bruton, Rosalinda H. Arends, Meina Liang, Anton I. Rosenbaum	12
11	Bioanalytical Methods and Strategic Perspectives Addressing the Rising Complexity of Novel Bioconjugates and Delivery Routes for Biotherapeutics 2022 ·BioDrugs ·(unknown), Jiaqi Yuan, Yue Huang, John K. Meissen, Si Mou, Meina Liang, Anton I. Rosenbaum	17
12	Characterization of Antibody–Drug Conjugate Pharmacokinetics and in Vivo Biotransformation Using Quantitative Intact LC-HRMS and Surrogate Analyte LC-MRM 2021 ·Analytical Chemistry ·Yue Huang, Si Mou, Yadi Wang, (unknown), Meina Liang, Anton I. Rosenbaum	33
13	Phase I Study of MEDI3726: A Prostate-Specific Membrane Antigen-Targeted Antibody–Drug Conjugate, in Patients with mCRPC after Failure of Abiraterone or Enzalutamide 2021 ·Clinical Cancer Research ·Johann S. de Bono, Mark T. Fleming, Judy S. Wang, Richard Cathomas, (unknown), John Bothos, Mary Jane Hinrichs, Qu Zhang, Peng He, Marna Williams, Anton I. Rosenbaum, Meina Liang, (unknown), Song Cho, Pablo Martínez, Daniel P. Petrylak	33
14	Differences in levels of phosphatidylinositols in healthy and stable Coronary Artery Disease subjects revealed by HILIC-MRM method with SERRF normalization 2021 ·PLoS ONE ·Yue Huang, (unknown), David Wen, Joseph Grimsby, Meina Liang, Anton I. Rosenbaum	6
15	Targeted oral peptide delivery using multi-unit particulates: Drug and permeation enhancer layering approach 2021 ·Journal of Controlled Release ·Puneet Tyagi, Ruchit Trivedi, Sergei Pechenov, Chandresh Patel, Jefferson D. Revell, (unknown), Yue Huang, Anton I. Rosenbaum, J. Anand Subramony	22
16	First-in-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody–Drug Conjugate MEDI4276 in Patients with HER2-positive Advanced Breast or Gastric Cancer 2021 ·Molecular Cancer Therapeutics ·Mark D. Pegram, Erika Hamilton, Antoinette R. Tan, Anna Maria Storniolo, Kemal Balic, Anton I. Rosenbaum, Meina Liang, Peng He, Shannon Marshall, (unknown), Mayukh Das, Manish R. Patel	73
17	Multifaceted Bioanalytical Methods for the Comprehensive Pharmacokinetic and Catabolic Assessment of MEDI3726, an Anti-Prostate-Specific Membrane Antigen Pyrrolobenzodiazepine Antibody–Drug Conjugate 2020 ·Analytical Chemistry ·Yue Huang, (unknown), Kemal Balic, William Mylott, Omnia A. Ismaiel, Eric Ma, (unknown), (unknown), Moucun Yuan, (unknown), (unknown), Diego Fernando Marmolejo Cortes, Lorin Roskos, Meina Liang, Anton I. Rosenbaum	20
18	Abstract 12342: LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Effects of the Anti-Endothelial Lipase Antibody MEDI5884 in Subjects With Stable CAD 2019 ·Circulation ·Christian T. Ruff, (unknown), Anton I. Rosenbaum, (unknown), (unknown), Sotirios K. Karathanasis, Judith Falloon, (unknown), (unknown), Judith Hsia, Boaz Hirshberg, Michael J. Koren, Marc S. Sabatine	1
19	Niemann‐Pick type C disease: molecular mechanisms and potential therapeutic approaches 2010 ·Journal of Neurochemistry ·Anton I. Rosenbaum, Frederick R. Maxfield	175
20	Chemical screen to reduce sterol accumulation in Niemann–Pick C disease cells identifies novel lysosomal acid lipase inhibitors 2009 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Anton I. Rosenbaum, Madalina Rujoi, Amy Y. Huang, Hong Du, Gregory A. Grabowski, Frederick R. Maxfield	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact